Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies

被引:0
|
作者
Laure Thibaudeau
Verena M. Quent
Boris M. Holzapfel
Anna V. Taubenberger
Melanie Straub
Dietmar W. Hutmacher
机构
[1] Queensland University of Technology,Regenerative Medicine Group, Institute of Health and Biomedical Innovation
[2] University Hospital Erlangen,Department of Obstetrics and Gynecology
[3] Friedrich-Alexander University Erlangen-Nuremberg,Orthopedic Center for Musculoskeletal Research
[4] University of Wuerzburg,George W Woodruff School of Mechanical Engineering
[5] Biotec TU Dresden,undefined
[6] Institute of Pathology,undefined
[7] Technical University Munich,undefined
[8] Georgia Institute of Technology,undefined
[9] Institute for Advanced Study,undefined
[10] Technical University Munich,undefined
来源
关键词
Bone metastasis; Breast cancer; Osteotropism; Humanized xenograft model; Tissue engineering;
D O I
暂无
中图分类号
学科分类号
摘要
Bone metastasis is a complication that occurs in 80 % of women with advanced breast cancer. Despite the prevalence of bone metastatic disease, the avenues for its clinical management are still restricted to palliative treatment options. In fact, the underlying mechanisms of breast cancer osteotropism have not yet been fully elucidated due to a lack of suitable in vivo models that are able to recapitulate the human disease. In this work, we review the current transplantation-based models to investigate breast cancer-induced bone metastasis and delineate the strengths and limitations of the use of different grafting techniques, tissue sources, and hosts. We further show that humanized xenograft models incorporating human cells or tissue grafts at the primary tumor site or the metastatic site mimic more closely the human disease. Tissue-engineered constructs are emerging as a reproducible alternative to recapitulate functional humanized tissues in these murine models. The development of advanced humanized animal models may provide better platforms to investigate the mutual interactions between human cancer cells and their microenvironment and ultimately improve the translation of preclinical drug trials to the clinic.
引用
收藏
页码:721 / 735
页数:14
相关论文
共 50 条
  • [31] A nanoagent for concurrent therapy of breast cancer bone metastasis and cancer-induced bone pain through SLC7A11 interruption and photodynamic therapy
    Qi Fu
    Zhongming Lian
    Mengya Niu
    Yaru Huang
    Yanqiu Ai
    Long He
    Dandan Zhang
    Cuixia Zheng
    Jian-Jun Yang
    Lei Wang
    Dandan Tian
    Chinese Chemical Letters, 2024, 35 (02) : 323 - 327
  • [32] Examination of the mechanism(s) of cancer-induced bone pain in animal models
    Ungard, R.
    Seidlitz, E.
    De Ciantis, P.
    Yashpal, K.
    Henry, J. L.
    Singh, G.
    BONE, 2011, 48 (01) : S39 - S39
  • [33] Breast tuberculosis with bone destruction mimicking breast cancer with bone metastasis: a case report and literature review
    Li, Li-Xin
    Wang, Ya-Wen
    Lin, Yuan
    Chen, Yan-Duo
    Chen, Xu
    Li, Xin
    Zhou, Xiao-Lin
    Su, Liang
    Lin, Mei-Ying
    Zhang, Kai
    GLAND SURGERY, 2024, 13 (10) : 1853 - 1862
  • [34] A nanoagent for concurrent therapy of breast cancer bone metastasis and cancer-induced bone pain through SLC7A11 interruption and photodynamic therapy
    Fu, Qi
    Lian, Zhongming
    Niu, Mengya
    Huang, Yaru
    Ai, Yanqiu
    He, Long
    Zhang, Dandan
    Zheng, Cuixia
    Yang, Jian-Jun
    Wang, Lei
    Tian, Dandan
    CHINESE CHEMICAL LETTERS, 2024, 35 (02)
  • [35] Potential Anti-Invasion Activity of Cathepsin K Inhibitors for the Treatment of Breast Cancer-Induced Bone Metastasis.
    Pickarski, M.
    Leung, P.
    Wesolowski, G. A.
    Duong, L. T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S441 - S441
  • [36] Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway
    Ouyang, Zhengxiao
    Guo, Xiaoning
    Chen, Xia
    Liu, Bo
    Zhang, Qiang
    Yin, Ziqing
    Zhai, Zanjing
    Qu, Xinhua
    Liu, Xuqiang
    Peng, Dan
    Shen, Yi
    Liu, Tang
    Zhang, Qing
    ONCOTARGET, 2018, 9 (02) : 1868 - 1884
  • [37] A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
    Jianxin Dai
    Bohua Li
    Jinping Shi
    Ling Peng
    Dapeng Zhang
    Weizhu Qian
    Sheng Hou
    Lei Zhao
    Jie Gao
    Zhiguo Cao
    Jian Zhao
    Hao Wang
    Yajun Guo
    Cancer Immunology, Immunotherapy, 2010, 59 : 355 - 366
  • [38] A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
    Dai, Jianxin
    Li, Bohua
    Shi, Jinping
    Peng, Ling
    Zhang, Dapeng
    Qian, Weizhu
    Hou, Sheng
    Zhao, Lei
    Gao, Jie
    Cao, Zhiguo
    Zhao, Jian
    Wang, Hao
    Guo, Yajun
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (03) : 355 - 366
  • [39] In vivo model of dormancy in ER breast cancer to bone metastasis
    Gawrzak, S.
    Guiu, M.
    Urosevic, J.
    Fernandez, E.
    Pavlovic, M.
    Gomis, R. R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S82 - S82
  • [40] Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
    Zinonos, Irene
    Luo, Ke-Wang
    Labrinidis, Agatha
    Liapis, Vasilios
    Hay, Shelley
    Panagopoulos, Vasilios
    Denichilo, Mark
    Ko, Chun-Hay
    Yue, Grace Gar-Lee
    Lau, Clara Bik-San
    Ingman, Wendy
    Ponomarev, Vladimir
    Atkins, Gerald J.
    Findlay, David M.
    Zannettino, Andrew C. W.
    Evdokiou, Andreas
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 532 - 540